You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 12, December 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (71)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psychiatry
 •Depression
 •Radiologic Imaging
 •PET/ SPECT Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Brain Serotonin Transporter Binding Potential Measured With Carbon 11–Labeled DASB Positron Emission Tomography

Effects of Major Depressive Episodes and Severity of Dysfunctional Attitudes

Jeffrey H. Meyer, MD, PhD, FRCPC; Sylvain Houle, MD, PhD, FRCPC; Sandra Sagrati, MEd; Anna Carella, BSc; Doug F. Hussey, BSc; Nathalie Ginovart, PhD; Verdell Goulding, BSc; James Kennedy, MD, PhD, FRCPC; Alan A. Wilson, PhD

Arch Gen Psychiatry. 2004;61:1271-1279.

Background  Although brain serotonin transporter (5-HTT) density has been investigated in subjects with a history of major depressive episodes (MDE), there has never been an investigation of brain 5-HTT during a current MDE. Brain 5-HTT binding potential (BP) may have an important role during MDE due to major depressive disorder, because the 5-HTT regulates extracellular 5-HT. The BP is an index of receptor density. Carbon 11–labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile (DASB) positron emission tomography (PET) is the first brain imaging technique that can measure the 5-HTT BP in cortical and subcortical brain regions in vivo. The purposes of this study were to investigate 5-HTT BP during MDE and to determine the relationship between 5-HTT BP and negativistic dysfunctional attitudes during MDE. Dysfunctional attitudes are negatively biased assumptions and beliefs regarding oneself, the world, and the future. Our recent publication of increased serotonin2 BP in MDE with severely negativistic dysfunctional attitudes suggests that this subgroup of MDE subjects has very low levels of extracellular serotonin.

Methods  Regional 5-HTT BP was measured in 20 nonsmoking medication-free (≥3 months) depressed subjects and 20 age-matched nonsmoking, medication-free, healthy subjects using [11C]DASB PET. Dysfunctional attitudes were measured using the Dysfunctional Attitudes Scale.

Results  No difference in regional 5-HTT BP was found between MDE and healthy subjects; however, the subgroup of MDE subjects with highly negativistic dysfunctional attitudes had significantly higher 5-HTT BP compared with healthy subjects in brain regions mainly sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, bilateral caudate, and bilateral putamen; average, 21% greater; F1,26, 5.6-12.2 [P values, .03-.002]). In the MDE subjects, increased 5-HTT BP was strongly associated with more negativistic dysfunctional attitudes in brain regions primarily sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, caudate, and putamen; r = 0.64-0.74 [P values, .003 to <.001]).

Conclusions  Serotonin transporters play an important role during depression. The magnitude of regional 5-HTT BP can provide a vulnerability to low levels of extracellular serotonin and symptoms of extremely negativistic dysfunctional attitudes.


Author Affiliations: Vivian M. Rakoff PET Imaging Centre (Drs Meyer, Houle, Ginovart, and Wilson; Mss Sagrati and Carella; and Messrs Hussey and Goulding), the Neurogenetics Section (Dr Kennedy), and the Mood Disorders Division (Dr Meyer), Centre for Addiction and Mental Health, and Department of Psychiatry (Drs Meyer, Houle, Ginovart, Kennedy, and Wilson; Mss Sagrati and Carella; and Messrs Hussey and Goulding), University of Toronto, Toronto, Ontario.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Brain Serotonin and Dopamine Transporter Bindings in Adults With High-Functioning Autism
Nakamura et al.
Arch Gen Psychiatry 2010;67:59-68.
ABSTRACT | FULL TEXT  

Brain Monoamine Oxidase A Binding in Major Depressive Disorder: Relationship to Selective Serotonin Reuptake Inhibitor Treatment, Recovery, and Recurrence
Meyer et al.
Arch Gen Psychiatry 2009;66:1304-1312.
ABSTRACT | FULL TEXT  

Seasonal Variation in Human Brain Serotonin Transporter Binding
Praschak-Rieder et al.
Arch Gen Psychiatry 2008;65:1072-1078.
ABSTRACT | FULL TEXT  

The Evolution of the Cognitive Model of Depression and Its Neurobiological Correlates
Beck
Am. J. Psychiatry 2008;165:969-977.
ABSTRACT | FULL TEXT  

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
Kish et al.
Brain 2008;131:120-131.
ABSTRACT | FULL TEXT  

5-HTT Binding in Recovered Depressed Patients and Healthy Volunteers: A Positron Emission Tomography Study With [11C]DASB
Bhagwagar et al.
Am. J. Psychiatry 2007;164:1858-1865.
ABSTRACT | FULL TEXT  

Human 5-HT Transporter Availability Predicts Amygdala Reactivity In Vivo
Rhodes et al.
J. Neurosci. 2007;27:9233-9237.
ABSTRACT | FULL TEXT  

Brain Serotonin Transporter Binding in Depressed Patients With Bipolar Disorder Using Positron Emission Tomography
Oquendo et al.
Arch Gen Psychiatry 2007;64:201-208.
ABSTRACT | FULL TEXT  

Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression.
Meyer et al.
Arch Gen Psychiatry 2006;63:1209-1216.
ABSTRACT | FULL TEXT  

Increased 5-HT2A Receptor Binding in Euthymic, Medication-Free Patients Recovered From Depression: A Positron Emission Study With [11C]MDL 100,907
Bhagwagar et al.
Am. J. Psychiatry 2006;163:1580-1587.
ABSTRACT | FULL TEXT  

Elevated Putamen D2 Receptor Binding Potential in Major Depression With Motor Retardation: An [11C]Raclopride Positron Emission Tomography Study
Meyer et al.
Am. J. Psychiatry 2006;163:1594-1602.
ABSTRACT | FULL TEXT  

Estimation of Serotonin Transporter Parameters with 11C-DASB in Healthy Humans: Reproducibility and Comparison of Methods
Frankle et al.
JNM 2006;47:815-826.
ABSTRACT | FULL TEXT  

PET Imaging of Serotonin Transporters with [11C]DASB: Test-Retest Reproducibility Using a Multilinear Reference Tissue Parametric Imaging Method
Kim et al.
JNM 2006;47:208-214.
ABSTRACT | FULL TEXT  

The Current State of Cognitive Therapy: A 40-Year Retrospective
Beck
Arch Gen Psychiatry 2005;62:953-959.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.